The EU AI Act is set to become one of the most comprehensive regulatory frameworks governing AI. For pharmaceutical and healthcare organizations, understanding its implications is critical to ensuring compliance, mitigating risks, and maintaining a competitive edge. During this session, Kerry Sheehan, AI Policy Expert, offers an exploration of the EU AI Act and its relevance to the healthcare sector. Attendees will gain actionable insights into the regulatory requirements, risk management strategies, and the steps necessary to align AI initiatives with the new regulations.

Key Takeaways:

• Key Provisions of the Act: Gain a detailed understanding of the classifications, requirements, and compliance obligations set out in the EU AI Act.
• Sector-Specific Implications: Learn how the regulations apply specifically to pharmaceuticals and healthcare
• Compliance and Risk Management: Discover best practices for aligning AI initiatives with regulatory requirements